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Abstract
Aims and subjects Burden of disease (BoD) estimates are
increasingly used in public health for assessing population
health. Disability Adjusted Life Years (DALYs)—a summary
measure frequently used in BoD studies—sum up the impact
on health due to premature death and non-fatal health outcomes
and allow for comprehensive and comparable assessments. To
provide first estimates on the burden of disease in North Rhine-
Westphalia (NRW), we calculated the burden due to premature
death using Standard Expected Years of Life Lost (SEYLL),
which is one of the two components of DALYs.
Materials and methods Methods provided by the World
Health Organisation (WHO) and developed for the Global
BoD (GBoD) study were used to estimate SEYLL in NRW
in 2005. We used administrative death and cause of death
statistics provided by local authorities.
Results In 2005, the total burden of disease due to
premature death was 1,774,926 SEYLLs. According to
the GBoD disease categories, non-communicable (group II)
diseases accounted for 89.1% of the burden. Communicable,
maternal, perinatal and nutritional (group I) conditions
contributed to 5.6% and injuries (group III conditions) to
5.3% of the total burden. The three leading single causes of
the burden of disease due to premature death were ischaemic
heart diseases, lung cancers and cerebrovascular diseases,
together accounting for 558,785 SEYLLs (32%).
Conclusion First estimates of the burden of disease were
feasible for NRW by use of WHO tools and administrative
data. The findings of our study are consistent with WHO
GBoD estimates and studies performed for other high-
income countries. Our SEYLL results usefully complement
the available health statistics highlighting diseases and
injuries leading to death at an early age of life. However,
our estimates are restricted to the impact of premature death
and do not provide information on non-fatal health out-
comes. Thus, future work should target estimates of the
Years of Life Lost due to Disability (YLD) to provide a
comprehensive assessment of the burden of disease in NRW.
Keywords Burden of disease .Mortality . Population
health . Years of life lost . Disability adjusted life years
Introduction
Comprehensive and comparable data on the health status of a
population are important for health policy decision-making
processes. Although the amount and quality of health data
have increased in the past, there are still difficulties in the
handling of these quantitative datasets, especially for policy
makers and researchers in Public Health (Boerma and
Stansfield 2007). One frequent limitation of health infor-
mation is the comparability of data, particularly with regard
to different health states or diseases. Also, the global
coverage of health data is distributed unequally with many,
especially low-income countries lacking information on
mortality in general and on a wide range of important
diseases (Boerma and Stansfield 2007).
To approach this problem, the World Health Organisation
(WHO), in cooperation with theWorld Bank and the Harvard
School of Public Health, developed the Global Burden of
Disease (GBoD) study in the late 1980s (Murray and Lopez
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1996). The main objective of the WHO GBoD Study was
firstly to create a standardised framework for integrating all
accessible information on mortality, causes of death, the
individual health status and disease-specific epidemiology,
and secondly to provide a comprehensive and comparable
overview of the levels of population health and the causes
of loss of health (Murray and Lopez 1996; Lopez et al.
2006). The GBoD estimates not only considered effects due
to premature mortality, but also included the burden due to
non-fatal health outcomes.
Summary Measures of Population Health (SMPH) are
qualified for burden of disease estimates because they
combine mortality and morbidity information and present
the health state of a particular population as a single
numerical index (Field and Gold 1998; Murray et al. 2002).
One common SMPH is the Disability Adjusted Life Year
(DALY), which was developed for the GBoD approach.
The DALY measure provides estimates on the burden of
disease by counting the years of healthy life lost in a
population (Lopez et al. 2006; Murray and Lopez 1997). In
particular, the DALY measure combines information on
Years of Life Lost due to premature death (YLL) with
information on Years of Life lost due to Disability (YLD)
(Lopez et al. 2006; Reidpath et al. 2003; WHO 2008).
Since the first published results of the GBoD study
(Murray and Lopez 1996), several other burden of disease
studies have been conducted based on the WHO method-
ology, not only at the national but also at the local level
(Michaud et al. 2006; Lozano et al. 2001; Mahapatra 2001;
Dodhia and Philips 2008).
For Germany there is only sparse information on the
burden of disease apart from the estimates that are available
from the WHO GBoD project (Murray et al. 1994; Lopez et
al. 2006). This contrasts with the fact that German health
data are largely available, compared to many other
countries with their own BoD estimates (Lozano et al.
1995; Naghavi et al. 2009). Therefore, the data situation in
Germany should allow for more sophisticated burden of
disease calculations. This paper provides first estimates on
the burden of disease in North Rhine-Westphalia (NRW),
which is a Federal State of Germany, using the WHO
GBoD methodology. Here we present the results of the
estimates on the burden due to premature death by
calculating Standard Expected Years of Life Lost (SEYLL)
for the year 2005.
Materials and methods
Population characteristics
North Rhine-Westphalia (Nordrhein-Westfalen) is located
in the Western part of Germany and accounts for about 17.9
million inhabitants, thus representing the most populous
Federal State in Germany (IT NRW 2008). Sharing
international boarders with Belgium and the Netherlands,
NRW also shares national boarders with other German
Federal States to the northern, eastern and southern parts.
The Federal State of North Rhine-Westphalia was estab-
lished by the British military administration in 1946 when
Germany was fragmented after World War II.
Data SEYLL estimates use aggregated datasets and are
calculated based on a standard life table (Model Life Table
West Level 26). In this life table, the standard of life
expectancy in optimal health at birth is set to 82.5 years for
women and 80 years for men. These standard values were
defined based on the highest observed life expectancy at the
time the first GBoD study was developed (Japanese women
82.4) (Murray 1994; Murray and Lopez 1996; Begg et al.
2007). To calculate the SEYLLs at any age of life, every
death that occurs before the ideal life expectancy is reached
is defined as premature and is multiplied with the life
expectancy at the age of death (Jamison et al. 2006; Murray
and Lopez 1996).
For SEYLLs in our study, information on population,
mortality and life expectancy data was needed. Population
data were taken from the Institute for Information Technol-
ogy in North Rhine-Westphalia (Infomationstechnologie
Nordrhein-Westfalen). For mortality we used administrative
data on mortality and causes of death for North Rhine-
Westphalia for the year 2005 from the regional statistical
and health authorities (Landesinstitut für Gesundheit und
Arbeit (LIGA), Informationstechnologie Nordrhein-
Westfalen (IT-NRW)). Additionally, we collected mortality
and causes of death data for the year 2001 to allow for first
comparisons over time for non-communicable diseases.
LIGA provides aggregated datasets based on death certif-
icates (Landesinstitut für Gesundheit und Arbeit des Landes
Nordrhein-Westfalen 2008). The datasets are stratified by
sex and age. Causes of death are classified according to the
WHO International Classification three-digit system (10th
revision; ICD 10; WHO 2007).
Conversion of data The calculation of the SEYLLs
required a redistribution of our recorded data because of
different age groups and a different disease classification
system used by the WHO tools. For disease classification,
WHO instruments use the Global Burden of Disease
classification system with a tree structure and four levels
of disaggregation including 108 conditions. At the first
level of disaggregation there are three broad groups of
disease entities:
(1) group 1 conditions: communicable, maternal, perina-
tal and nutritional conditions; (2) group 2 conditions: non-
communicable diseases; (3) group 3 conditions: injuries.
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According to the WHO manual, the ICD coded data
record was adjusted for the GBoD disease classification
system and adopted according to the GBoD age groups
(Lopez et al. 2006). The GBoD classification contains age
groups starting with neonatal children and continuing with
5-year age groups until the age of 85 years. People above
the age of 85 are combined in the 85+ group.
Use of WHO templates For calculation of estimates on
SEYLLs due to premature mortality, the WHO presents three
different templates (WHO 2008). Aiming at consistency of
the recorded dataset the first template ensures quality of age,
gender and disease-specific conditions. Another important
objective is the redistribution of ill-defined and other not
specifically coded or even miscoded data to the 108 disease-
specific conditions of the GBoD tree structure. This is of
high importance for information on cardiovascular diseases
data, which have been demonstrated to be associated with a
high proportion of misclassification (Lozano et al. 2001).
The redistribution of the ill-defined conditions is described
elsewhere (Mathers et al. 2001; WHO 2008). In a last step,
the adjusted data record was used for calculating the age- and
sex-specific SEYLLs. The template allows for SEYLL
results both with and without a 3% time discount rate.
Futhermore, the calculations allow for SEYLL estimates
with and without an age-weighting function. For the
description of our results we used the 3% time discount
and uniform age weighting scenario in order to make our
results comparable to the findings of the GBoD study.
Results
Total burden of disease due to premature death
The total burden due to premature mortality for North
Rhine-Westphalia with 3% time discount and uniform age-
weighting accounts for 1,744,926 SEYLLs. Men and
women contribute to 916,979 (52.6%) and 827,947
(47.4%) SEYLLs, respectively; 89.1% (1,555,709
SEYLLs) of the burden was caused by group 2 conditions.
The proportions of group 1 and group 3 conditions account
for 5.6 and 5.3%, respectively.
Figure 1 shows the distribution of the three main disease
entities stratified by age groups for NRW; 58.1% (12,456
SEYLLs) of neonatal children are mostly affected by group
1 conditions. The proportion decreases continuously with
an increase in age until, at the age group of 10–14 years, the
percentage of 5.6% (114,9 SEYLLs) is reached. After that,
the percentage remains constant. The percentage of group 2
diseases increases in the population above the age group of
20–24 years and peaks at about 93.2% (209,286 SEYLLs)
in the age group of 65–69 years. For group 3 conditions,
the proportion of SEYLLs increases beginning with the age
group of 1–4 years and peaks with 54.1% (6,086 SEYLLs)
at the age group of 20–24 years. It then decreases in older
ages with a minimum of 2% (4,833 SEYLLs) at the age
group of 75–79 years.
Group 1 conditions (communicable, maternal, perinatal
and nutritional conditions) The total burden due to
communicable diseases was 97,056 SEYLLs (5.6%).
Lower respiratory infections caused the major burden of
group 1 conditions with 39,218 SEYLLs (40.4%), followed
by low birth weight and diarrhoeal diseases with 8,338
SEYLLs (8.6%) and 3,956 SEYLLs (4.1%), respectively
(Table 1).
The female population is burdened by 47,693 SEYLLs
(49.1%) and the male population by 49,364 SEYLLs
(50.9%) due to group 1 diseases. Lower respiratory
infections are the leading single cause of SEYLLs for both
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Fig. 1 Distribution of SEYLLs in NRW 2005 (both genders)
Table 1 Leading causes of SEYLLs by communicable diseases
(NRW 2005)
No. The ten leading causes of SEYLLs
because of group 1 conditions
Total
1. Lower respiratory infections 39,218.59
2. Low birth weight 8,338.96
3. Diarrhoeal diseases 3,956.11
4. Hepatitis B 3,440.18
5. Hepatitis C 3,069.47
6. HIV/AIDS 2,552.03
7. Meningitis 1,319.70
8. Birth asphyxia and birth trauma 1,286.63
9. Tuberculosis 826.77
10. Iron-deficiency anaemia 473.99
*Other conditions: neoplasms, endocrine disorders, sense organ
diseases, genitourinary diseases, skin diseases, musculoskeletal dis-
eases, congenital anomalies, oral conditions, genitourinary diseases
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men and women, accounting for 18,598 SEYLLs (19.2%)
and 20,620 SEYLLs (21.2%), respectively.
Group 2 conditions (non-communicable diseases) The
overall disease burden due to group 2 conditions accounts
for 1,555,709 SEYLLs (89.1%). Cardiovascular diseases
and malignant neoplasms are the leading disease entities
and account for 653,398 SEYLLs (42%) and 606,727
SEYLLs (39%), respectively (Fig. 2).
Table 2 shows the SEYLL ranking of single group 2
conditions. Ischaemic heart disease is the leading single
group 2 condition, accounting for 321,617 SEYLLs
(20.7%), followed by tracheal, broncheal and lung cancers,
with cerebrovascular diseases adding another 131,529
SEYLLs (8.4%) and 105,639 SEYLLs (6.8%), respectively
(Table 2).
The male population has a burden of 804,217 SEYLLs
(51.7%) and the female population of 751,492 SEYLLs
(48.3%) due to group 2 conditions. Both men and women are
mostly affected by the impact of ischaemic heart disease with
182,777 (11.8%) and 138,839 (8.9%) SEYLLs, respectively.
SEYLL rates were also calculated for the group 2
conditions (Fig. 3). Therefore, the population of North
Rhine-Westphalia stratified by age groups and sex for the year
2005 was taken as a denominator to calculate rates per
100,000 citizens. Figure 3 shows the distribution of SEYLLs
caused by non-communicable diseases for the male and
female population by age groups. The trend for the female
population differs in the gradient of the rates. The gradient
for the female population is lower but peaks at the age 85+
group with about 59,420 SEYLLs/100,000. Men in this age
group demonstrate 50,335 SEYLLs/100,000.
Compared to the year 2005, the burden of disease due to
premature death in 2001 accounted for 1,769,799 SEYLLs.
SEYLL rates for group 2 conditions remained constant till
the age of 44 years. For people above 70 years of age, the
burden due to premature death in 2005 decreased compared
to 2001 (Fig. 4).
Group 3 conditions (injuries) The burden of injuries
accounts for 92,161 SEYLLs (5.3%). Unintentional injuries
and intentional injuries add 59,379 SEYLLs (64.4%) and
32,782 SEYLLs (35.6%) to the burden due to group 3
conditions, respectively. Self-inflicted injuries with 30,930
SEYLLs (33.6%), road traffic accidents with 18,741
SEYLLs (20.3%) and falls with 15,357 SEYLLs (16.7%)
cause the major burden due to injuries.
Men have a burden of 63,398 SEYLLs (68.8%) and
women of 28,762 SEYLLs (31.2%). Both men and women
are highly affected by self-inflicted injuries with 22,792
SEYLLs (27.7%) and 8,137 SEYLLs (8.8%), respectively.
Discussion
The BoD approach is increasingly used in international
public health for assessing a population’s health status at
national or local levels (Michaud et al. 2006; Lozano et al.
2001; Mahapatra 2001; Dodhia and Philips 2008). This is
the first study to present the BoD due to premature death
for NRW, a Federal State of Germany, by use of SEYLLs
according to the methods developed by the WHO GBoD
project.
SEYLLs are the component of the DALY measure that
represent the mortality burden and are usually combined
with the YLDs representing the burden due to non-fatal
health outcomes. We calculated the SEYLL measure due to
data availability and quality. SEYLLs are usually easier to
estimate than YLDs because they mainly require cause of
death statistics. For reasons of feasibility, we thus focused
on SEYLL estimates in our study.
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Fig. 2 SEYLLs caused by non-communicable diseases (NRW 2005;
both genders)
Table 2 Top ten leading causes of SEYLLs by non-communicable
diseases (NRW 2005)
No. The ten leading causes of SEYLLs
because of group 2 conditions
Total
1. Ischaemic heart disease 321,617.27
2. Tracheal, broncheal, lung cancers 131,529.35
3. Cerebrovascular disease 105,639.11
4. Colon and rectum cancers 70,878.60
5. Breast cancer 59,348.63
6. Chronic obstructive pulmonary disease 58,864.31
7. Cirrhosis of the liver 43,541.65
8. Hypertensive heart disease 38,850.47
9. Diabetes mellitus 33,083.27
10. Stomach cancer 28,411.21
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Our results are in good agreement with other findings
from WHO GBoD studies for high-income countries where
non-communicable diseases are the predominant group of
diseases contributing to the burden of disease. For NRW,
we estimated a proportion of 89.1% of the total SEYLL
burden in 2005, which is in good agreement with Michaud
et al. who reported a proportion of 80% of DALYs for
group 2 conditions in the USA. As in other high-income
countries, most of the SEYLL burden in NRW was caused
by cardiovascular diseases and malignant neoplasms with
42% and 39%, respectively. We identified ischaemic heart
disease as the leading single condition contributing to the
SEYLLs for both men and women. Similar patterns were
reported for the USA (Michaud et al. 2006) and in other
high-income countries (Murray et al. 2001).
Group 1 (communicable, maternal, perinatal and nutri-
tional) conditions caused a seemingly negligible burden
with 5.6% of the total SEYLLs in NRW, but should not be
taken out of consideration because they affect especially
children and young adults.
Injuries (group 3 conditions) contributed to 5.3% of the
total SEYLLs in our estimates, with self-inflicted injuries
being the leading single cause within this group of conditions.
Like for group 1 and 2 conditions, our estimates are similar to
findings from the GBoD study for the European region
(Murray et al. 2001).
A considerable limitation of the exclusive use of
SEYLLs for BoD assessments is the fact that non-fatal
health outcomes with a high prevalence in a population are
not represented, e.g., unipolar depressive or alcohol use
disorders. SEYLLs use cause of death statistics and, in
contrast to studies using Disability Adjusted Life Years, do
not include any information on non-fatal health outcomes.
Compared to causes of death statistics using death
numbers, the use of SEYLLs results in a different description
of population health. In burden of disease studies health
losses are counted in years of life and therefore highlight
diseases and injuries leading to death at an early age of life.
For instance, in our study we identified self-inflicted injuries
to be among the ten most common single health conditions
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contributing to the male burden of disease in NRW. When
using death numbers, the ranking is considerably differant,
with self-inflicted injuries only ranking at the 18th place. For
women, similar observations can be made. Many studies
have concluded that the SEYLL is a more comprehensive
measure of the impact of premature death on health than
measures such as death counts or death rates (Mariotti et al.
2003; Vlajinac et al. 2008). The use of the SEYLL measure
gives a higher weight to conditions that affect young people
than to conditions affecting older people (Vlajinac et al.
2008; Mariotti et al. 2003).
There are several possibilities to measure Years of Life
Lost, depending on the health goal to which the losses are
referred. Potential Years of Life Lost (PYLL), e.g., is an
alternative measure that is used by the regional health
authorities in NRW (LIGA 2005) for estimating the burden
of disease due to premature death. The PYLL measure in
NRW sets a fixed limit to life expectancy at 65 years of age,
and thus does not take into account any deaths occurring
beyond this threshold. In conclusion, PYLLs do not assess
any burden of premature mortality for the age groups above
65 years of age, and so any health benefits to people in a
later stage of life are not assessed when using PYLLs. In
contrast, the SEYLL approach uses the remaining life
expectancy at any age of life as reference, and thus every
event of death contributes to the burden.
This study has shown that burden of disease estimates
based on the WHO GBoD methodology is feasible at a local
level. Furthermore, we believe that our SEYLL estimates
complement the available health statistics for describing the
health status of the NRW population in a very useful manner.
However, our findings are limited to mortality and do not
provide any information on the burden due to non-fatal health
outcomes. In the future, we therefore aim at to calculate the
Years of Life lost due to Disability (YLD) in order to include
the impact of non-fatal health outcomes into our burden of
disease estimates. Information on incidence, duration of
disease and disability weights is needed to perform YLD
calculations and thus to allow for a comprehensive assessment
of the burden of disease in NRWby use of the DALYmeasure.
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